Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $0.7652W HIGH $32.52
Volume
408.79 K
Value Traded
389.64 K
Short % Float
1.81%
-33.62%Week
-42.66%1 Month
-74.4%3 Month
-83.25%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
755.30 K
EPS (TTM)
-6.67
P/E Ratio
-
Ent. Value
-168.97 K
Total Shares
888.59 K
Float Shares
430.00 K
Insiders
64.10%
Institutions
3.83%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
MNDR Catalyst Timeline
Dated clinical, regulatory and corporate events for Mobile-health Network Solutions Class A Ordinary Shares
Past FDA Catalysts and PDUFA Decisions
How MNDR actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Mobile-health Network Solutions Class A is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every MNDR program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Teoh Pui PuiDirector, Officer (Co-Chief Executive Officer), 10% Owner | Grant/Award | 750,000 816,520 held | $0.00 | 04/30/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in MNDR
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in MNDR for Q2 2026. | ||||
MNDR Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How MNDR ranks across every disease it competes in
Competitive Position is a premium feature
See how MNDR ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialMNDR News
-MNDR
May 18, 2026MOBILE-HEALTH NETWORK SOLUTIONS 2 Venture Drive, #07-08 Vision Exchange Singapore 608526 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To be held on
Mobile-health Network Solutions is scheduled to hold an Extraordinary General Meeting (EGM) on June 8, 2026, at 10 p.m. Singapore time. The meeting will occur virtually, enabling eligible shareholders and appointed proxyholders to participate and vote online. Key proposals include a share consolidation and the creation of a new class of ordinary shares. Shareholders must register in advance and submit their proxies no later than 48 hours before the meeting to ensure representation.
Read more →-MNDR
May 13, 2026Mobile-health Network Solutions Enters into Non-binding
Mobile-health Network Solutions (MNDR) has signed a non-binding strategic memorandum with White Group Pte. Ltd. to facilitate up to $100 million in private equity funding aimed at expanding its AI-powered healthcare services. The funding will specifically support the development of advanced sports health and physiotherapy programs. White Group intends to identify a U.S.-based private equity fund for this collaboration, bringing MNDR closer to its goal of enhancing healthcare technology operations on a global scale. The roadmap ensures compliance with regulatory standards while aiming for a funding presentation within two months.
Read more →-MNDR
May 4, 2026▲ +26.3%on this news
Mobile-health Network Solutions Enters into Non-binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa
Mobile-health Network Solutions (MNDR) has entered a non-binding agreement with Hector Capital, where Hector Capital will invest up to $119 million for the acquisition of majority stakes in BIMA and M&M Helix. This strategic partnership aims to enhance MNDR's AI-powered healthcare solutions across Asia and Africa. The investment will support the integration of these platforms, aiming to broaden healthcare accessibility and improve operational efficiency. The finalization of this arrangement is subject to regulatory approvals and a comprehensive review of the acquired companies.
Read more →-MNDR
Mar 12, 2026Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026
Mobile-health Network Solutions (MNDR) reported strong financial results for the first half of fiscal 2026, including a notable increase in gross margin and cash position. The company achieved a gross margin of 20.1%, up from 14.8% in the same period last year, driven by a reduction in the cost of revenue. Operating expenses were cut by nearly 30%, resulting in a lower net loss of $0.86 million, a significant improvement from the previous year's loss. These advancements are attributed to the company's focus on AI integration into its operations.
Read more →-MNDR
Feb 12, 2026RULES OF THE MHNS EMPLOYEE INCENTIVE PLAN 1. NAME OF THE PLAN The " MHNS Employee Incentive Plan " (hereinafter referred to as the " Plan ") has been established by Mobile-health Network Solutions, an exempted company in
Mobile-health Network Solutions has established the "MHNS Employee Incentive Plan" aimed at providing employees with incentives through share options. The plan allows for a maximum of 15% of the total issued Class A and Class B shares to be utilized for awards granted each financial year. Participants in the plan will need to bear any taxes incurred from the exercise of the awards, and the plan is governed by the laws of the Republic of Singapore. The plan's details also outline the rights and obligations of both the company and employees participating in the incentive structure.
Read more →-MNDR
Jan 13, 2026Mobile-health Network Solutions Announces Change of Address effective March 1, 2026
Mobile-health Network Solutions, a leading AI HealthTech platform, will change its address to 2 Venture Drive, #07-08, Vision Exchange, Singapore, effective March 1, 2026. This relocation is intended to improve operations and better serve their clients and partners. The company continues to expand its digital health services across Southeast Asia and into the US market, focusing on telemedicine and AI-driven health tools.
Read more →-MNDR
Oct 31, 2025Mobile-health Network Solutions Reports FY2025 Results and Operational Update
Mobile-health Network Solutions (MNDR) reported its FY2025 financial results, highlighting a transition to an asset-light virtual-care platform which reduced operational costs. The company incurred a narrowed net loss of $3.4 million, despite a significant decline in revenue of 45.3% due to its shift away from legacy clinic operations. MNDR is committed to scaling its AI-driven health solutions and has initiated strategic partnerships in both Asia and Africa to enhance access to virtual care in underserved communities. The launch of innovative tools, including AI Checker and Aiko, illustrates its focus on leveraging technology to improve healthcare outcomes.
Read more →-MNDR
Aug 25, 2025MOBILE-HEALTH NETWORK SOLUTIONS 2 Venture Drive, #07-06/07 Vision Exchange Singapore 608526 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To be held on
Mobile-health Network Solutions has announced an Extraordinary General Meeting (EGM) for shareholders to be held virtually on September 11, 2025. The meeting will address crucial matters, including a proposed share consolidation and amendments to the articles of association. Shareholders are encouraged to register in advance to participate in the virtual meeting and vote on the proposals. Proxy materials will be distributed to shareholders by August 25, 2025, detailing the agenda and voting procedures.
Read more →-MNDR
Aug 21, 2025INSIDER TRADING AND CONFIDENTIALITY POLICY As adopted by the Board of Directors , effective 19 Aug 2025 This Policy confirms procedures which consultants, advisors, employees, officers and directors of Mobile-health Netw
Mobile-health Network Solutions has adopted an Insider Trading and Confidentiality Policy effective from August 19, 2025. The policy outlines procedures for consultants, advisors, employees, officers, and directors regarding the handling of material nonpublic information. It emphasizes the prohibition of trading company stock based on undisclosed information, alongside regulations around pre-clearance for transactions. The policy also allows for modifications as deemed necessary by the Board of Directors.
Read more →-MNDR
Jun 13, 2025Mobile-health Network Solutions Announces H1 FY2025 Results; Continues on Drive Towards Scale and Profitability
Mobile-health Network Solutions (MNDR) reported its financial performance for H1 FY2025, revealing a decline in revenue and an increase in net loss compared to the same period last year. The reduction in revenue was primarily attributed to the closure of its CityGate clinic in Singapore, which affected telemedicine usage. However, the company is optimistic about its transition towards a leaner, AI-focused business model, bolstered by a recent acquisition and ongoing innovations in telehealth services. MNDR aims to achieve breakeven by H2 FY2026 and expresses confidence in returning to profitability by H1 FY2027.
Read more →-MNDR
Feb 14, 2025▼ -8.6%on this news· ran to +151% by day 3
STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this " Agreement ") dated as of
MOBILE-HEALTH NETWORK SOLUTIONS has entered into a Standby Equity Purchase Agreement with YA II PN, LTD., enabling the company to issue and sell up to $10 million of its Class A ordinary shares. This agreement is structured to provide the investor with the flexibility to purchase shares intermittently throughout the commitment period. The transaction relies on exemptions from the Securities Act, indicating the company aims to streamline its equity financing process. Overall, this move could provide significant funding for future company endeavors.
Read more →-MNDR
Dec 24, 2024Mobile-health Network Solutions Announces Closing of City Gate Clinic, Charts Path Forward in 2025 SINGAPORE
Mobile-health Network Solutions (MNDR) has announced the closure of its City Gate Clinic due to the revocation of its license by the Ministry of Health. Despite this setback, the company reported that its teleconsultation division has successfully recovered to about 55% of its pre-incident revenue levels. MNDR aims to support affected patients by directing them to alternative clinics within its network. Additionally, the company continues to expand its services across Asia-Pacific and is focused on developing an AI-powered healthcare platform.
Read more →-MNDR
Sep 20, 2024Mobile-health Network Solutions Delinquency Notification Letter from Nasdaq SINGAPORE
Mobile-health Network Solutions (MNDR) has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, as its Class A ordinary shares have been priced below $1.00 for 30 consecutive business days. The company has a compliance period until March 17, 2025, to regain compliance, during which it may also qualify for an additional grace period. Despite this notification, MNDR's shares will continue to trade without interruption, and the company has been recognized as a significant player in the telehealth sector in Asia-Pacific.
Read more →-MNDR
May 21, 2024Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024 SINGAPORE
Mobile-health Network Solutions (MNDR) reported a significant revenue increase of approximately 120% for the first half of fiscal 2024, reaching about $6.6 million compared to $3.0 million during the same period in 2023. The growth is attributed to higher consultation numbers and enhanced pricing models, alongside improvements in service workflow efficiency. Despite this revenue growth, the company faced an increased net loss, indicating challenges in scaling operations. Overall, these results affirm the company's vision of expanding telehealth services beyond Singapore.
Read more →-MNDR
Apr 22, 2024APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 SINGAPORE
Mobile-health Network Solutions (MNDR) has announced its anticipated financial results for the first half of 2024, projecting revenue growth of around 100% compared to the same period last year. The company reports an increase in demand for its telemedicine services, with an average of 119,000 monthly sessions, indicating strong adoption. CEO Dr. Rachel Teoh highlighted the ongoing growth potential in the Singapore market due to low penetration rates. The final financial results will be filed with the SEC by June 30, 2024.
Read more →-MNDR
Apr 12, 2024▲ +47.1%on this news· ran to +77% by day 3
Mobile-health Network Solutions Announces Closing of Initial Public Offering SINGAPORE
Mobile-health Network Solutions (MNDR) has successfully closed its initial public offering, raising a total of $9.0 million by selling 2,250,000 Class A Ordinary Shares at $4.00 each. The company's shares began trading on the NASDAQ Stock Market under the ticker symbol 'MNDR' on April 10, 2024. This IPO highlights the company's commitment to providing leading telehealth solutions in Singapore and across the APAC region using its MaNaDr platform. However, concerns about market conditions and potential risks related to forward-looking statements remain.
Read more →-MNDR
Apr 9, 2024Mobile-health Network Solutions Announces Pricing of $9 Million Initial Public Offering SINGAPORE
Mobile-health Network Solutions (MNDR) announced the pricing of its initial public offering, which includes 2,250,000 Class A Ordinary Shares at $4.00 per share. The public offering is expected to generate gross proceeds of approximately $10.35 million if the underwriter's option for additional shares is exercised. The shares are slated to begin trading on NASDAQ under the MNDR ticker symbol, with the offering expected to close around April 12, 2024, subject to customary conditions. This marks a significant milestone for the telehealth solutions provider based in Singapore.
Read more →About Mobile-health Network Solutions Class A Ordinary Shares
BIOPHARMAWATCH ELITE PLUS
Trade the next MNDR catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime